Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krauth

Showing results (571-580 of 593) with videos related to

Pageof 60
Sort By:
American Journal of Hematology|February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasmsDaniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.
Leukemia & Lymphoma|April 10, 2020
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myelomaKatja Weisel, Meletios Dimopoulos, Philippe Moreau, et al.
Eclinicalmedicine|July 16, 2024
Evidence for exercise-based interventions across 45 different long-term conditions: an overview of systematic reviewsGrace O Dibben, Lucy Gardiner, Hannah M L Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 miceJames S Friedman, Bo Chang, Daniel S Krauth, et al.
BMC Medicine|January 8, 2025
Multimorbidity clusters and their associations with health-related quality of life in two UK cohortsLewis Steell, Stefanie J Krauth, Sayem Ahmed, et al.
The European Physical Journal. A, Hadrons and Nuclei|February 8, 2023
Muonic atom spectroscopy with microgram target materialA Adamczak, A Antognini, N Berger, et al.
Eclinicalmedicine|July 24, 2024
Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohortsStefanie J Krauth, Lewis Steell, Sayem Ahmed, et al.
Psychiatry Research|April 26, 2025
Mental disorders in people with undiagnosed diseases presenting to German centres for rare diseases - prevalence, type and relevanceJan Dieris-Hirche, Stephan Herpertz, Helge Hebestreit, et al.
Eclinicalmedicine|October 19, 2023
Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort designHelge Hebestreit, Anne-Marie Lapstich, Lilly Brandstetter, et al.
Acta Neuropathologica|April 23, 2013
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's diseaseJens Wagner, Sergey Ryazanov, Andrei Leonov, et al.
Pageof 60

Showing results (571-580 of 593) with videos related to

Sort By:
Pageof 60
American Journal of Hematology|February 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasmsDaniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, et al.
Leukemia & Lymphoma|April 10, 2020
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myelomaKatja Weisel, Meletios Dimopoulos, Philippe Moreau, et al.
Eclinicalmedicine|July 16, 2024
Evidence for exercise-based interventions across 45 different long-term conditions: an overview of systematic reviewsGrace O Dibben, Lucy Gardiner, Hannah M L Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 miceJames S Friedman, Bo Chang, Daniel S Krauth, et al.
BMC Medicine|January 8, 2025
Multimorbidity clusters and their associations with health-related quality of life in two UK cohortsLewis Steell, Stefanie J Krauth, Sayem Ahmed, et al.
The European Physical Journal. A, Hadrons and Nuclei|February 8, 2023
Muonic atom spectroscopy with microgram target materialA Adamczak, A Antognini, N Berger, et al.
Eclinicalmedicine|July 24, 2024
Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohortsStefanie J Krauth, Lewis Steell, Sayem Ahmed, et al.
Psychiatry Research|April 26, 2025
Mental disorders in people with undiagnosed diseases presenting to German centres for rare diseases - prevalence, type and relevanceJan Dieris-Hirche, Stephan Herpertz, Helge Hebestreit, et al.
Eclinicalmedicine|October 19, 2023
Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort designHelge Hebestreit, Anne-Marie Lapstich, Lilly Brandstetter, et al.
Acta Neuropathologica|April 23, 2013
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's diseaseJens Wagner, Sergey Ryazanov, Andrei Leonov, et al.
Pageof 60